Thesis
Given the recent strong Q2 results and raised full-year guidance for Booz Allen Hamilton, I anticipate that the stock will experience a positive momentum. Despite a downgrade from JP Morgan, I see an opportunity to short BAH as its exceptional growth is likely to normalize, making it overvalued in the current market.